Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
Top Cited Papers
Open Access
- 31 August 2012
- journal article
- clinical trial
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 19 (1), 117-122
- https://doi.org/10.1016/j.bbmt.2012.08.014
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Unmanipulated HLA‐mismatched/haploidentical peripheral blood stem cell transplantation for high‐risk hematologic malignanciesTransfusion, 2012
- Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood graftsBlood, 2011
- Cyclophosphamide and cancer: golden anniversaryNature Reviews Clinical Oncology, 2009
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- The history and future prospective of haplo-identical stem cell transplantationCytotherapy, 2008
- Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantationBlood, 2006
- Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of RelapseJournal of Clinical Oncology, 2005
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeThe New England Journal of Medicine, 1998
- Cyclophosphamide-Induced Immunological Tolerance: an OverviewImmunobiology, 1996
- Production of Graft-Versus-Host Disease in the Rat and its Treatment with Cytotoxic AgentsNature, 1966